Department of Laboratory Medicine, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310000, China; Key Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province, Hangzhou, 310000, China; Institute of Laboratory Medicine, Zhejiang University, Hangzhou, 310000, China.
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310000, China.
J Hazard Mater. 2021 Jan 15;402:123771. doi: 10.1016/j.jhazmat.2020.123771. Epub 2020 Aug 25.
Understanding the transmission mechanism of SARS-CoV-2 is a prerequisite to effective control measures. To investigate the potential modes of SARS-CoV-2 transmission, 21 COVID-19 patients from 12-47 days after symptom onset were recruited. We monitored the release of SARS-CoV-2 from the patients' exhaled breath and systematically investigated environmental contamination of air, public surfaces, personal necessities, and the drainage system. SARS-CoV-2 RNA was detected in 0 of 9 exhaled breath samples, 2 of 8 exhaled breath condensate samples, 1 of 12 bedside air samples, 4 of 132 samples from private surfaces, 0 of 70 samples from frequently touched public surfaces in isolation rooms, and 7 of 23 feces-related air/surface/water samples. The maximum viral RNA concentrations were 1857 copies/m in the air, 38 copies/cm in sampled surfaces and 3092 copies/mL in sewage/wastewater samples. Our results suggest that nosocomial transmission of SARS-CoV-2 can occur via multiple routes. However, the low detection frequency and limited quantity of viral RNA from the breath and environmental specimens may be related to the reduced viral load of the COVID-19 patients on later days after symptom onset. These findings suggest that the transmission dynamics of SARS-CoV-2 differ from those of SARS-CoV in healthcare settings.
了解 SARS-CoV-2 的传播机制是采取有效控制措施的前提。为了研究 SARS-CoV-2 的潜在传播模式,我们招募了 21 名发病后 12-47 天的 COVID-19 患者。我们监测了患者呼出的呼吸中 SARS-CoV-2 的释放情况,并系统地调查了空气、公共表面、个人必需品和排水系统的环境污染情况。在 9 份呼出的呼吸样本中,0 份检测到 SARS-CoV-2 RNA,在 8 份呼出的呼吸冷凝物样本中,2 份检测到 SARS-CoV-2 RNA,在 12 份床边空气样本中,1 份检测到 SARS-CoV-2 RNA,在 132 份私人表面样本中,4 份检测到 SARS-CoV-2 RNA,在 70 份隔离病房中经常接触的公共表面样本中,0 份检测到 SARS-CoV-2 RNA,在 23 份与粪便相关的空气/表面/水样本中,7 份检测到 SARS-CoV-2 RNA。空气中的最大病毒 RNA 浓度为 1857 拷贝/毫升,采样表面的病毒 RNA 浓度为 38 拷贝/平方厘米,污水/废水样本中的病毒 RNA 浓度为 3092 拷贝/毫升。我们的结果表明,SARS-CoV-2 可通过多种途径在医院环境中发生传播。然而,呼吸样本和环境样本中病毒 RNA 的低检测频率和有限数量可能与 COVID-19 患者在症状出现后几天病毒载量降低有关。这些发现表明,SARS-CoV-2 的传播动力学在医疗机构中与 SARS-CoV 不同。